• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Blood Donation

Prediction of Vasovagal Reactions in Whole Blood Donors Using a Scoring System

Previous studies have identified risk factors for vasovagal reactions (VVRs) in blood donors, including young age, female sex, lower body…

January 17, 2024

Variability of Blood Donor Incentives Globally

Although the WHO recommends that blood collection establishments (BCEs) rely on voluntary, non-remunerated donations, a new study recently published by…

December 20, 2023

Novel Technology-Enabled Personalized Nomogram Increases Plasma Yield from Donations

Beginning in 1992, the U.S. has used a standard weight-based nomogram to guide appropriate plasma collection targets—15% to 42% of…

November 29, 2023

Frequent Platelet Donation and Risk for T-cell Lymphopenia

In the United States, over 90% of platelets are collected by plateletpheresis, and donors may give platelets up to 24…

November 22, 2023

Lymphopenia from Plateletpheresis does not Affect Immune Response

Leukoreduction during plateletpheresis is routinely performed to prevent alloimmunization and febrile reactions when platelets are transfused.  In 1988, the U.S….

August 2, 2023

Frequent Whole Blood Donations Not Associated with Cardiovascular Disease

Few studies have examined the effects on whole blood (WB) donations on cardiovascular health.  Researchers associated with the Australian Red…

May 17, 2023

Individual Risk Assessment Questions for Potential Donors at Higher Risk for HIV

In January 2023, the U.S. FDA issued draft guidance recommending individual risk-based assessments for potential donors at higher risk for…

April 26, 2023

Randomized Trial Results on Donor Sex and RBC Recipient Mortality

Observational studies and systematic reviews have found conflicting results on the association between RBC donor sex and associated transfusion recipient…

April 18, 2023

Whole Blood Derived Platelet vs. Apheresis Platelets

During the COVID-19 pandemic, the U.S. experienced significant blood product shortages. In 2019, approximately 2.5 million platelet units were collected…

April 12, 2023

Individualized Behavior-Based MSM Donor Eligibility Would Increase Pool of Potential Donors

In order to reduce the risk of blood transfusion-associated HIV transmission during the window period between exposure and detectability among…

October 12, 2022

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Interim pages omitted …
  • Page 13
  • Go to Next Page »

Primary Sidebar

Latest News

  • Cryopreserved vs. Standard Platelets for Surgical Bleeding

  • Phosphatidylserine and Phosphatidylethanolamine Levels on RBCs Important for Transfusion Outcomes

  • Blood Donation and Improved Cardiometabolic Health

  • Mitochondrial DNA Acts as a “First Hit” for Antibody-Mediated TRALI

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley